skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PharmaLogo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

80 Total results for product and free and sample content found

Citeline

Immuno-Oncology (IO) in Non-Small Cell Lung Cancer (NSCLC)

By Doro Shin 23 Nov 2018

A clinical review of the competitive landscape, approved therapies, trial outcomes and experienced investigators in this highly targeted space.

Topic Cancer

View infographic

Datamonitor Healthcare

Neuropathic Pain Market and Forecast Analysis to 2026

By Nicola Sawalhi-Leckenby 07 Sep 2018

Big changes are coming to the neuropathic pain market – are you prepared? Take a look at the projected neuropathic pain drug sales for the US, Japan, and five EU nations with the latest infographic from Datamonitor Healthcare. This snapshot view of the future of the neuropathic pain market is packed with data from the full Datamonitor Healthcare Neuropathic Pain Disease Coverage report.

View infographic

Medtrack

Medtrack Patent Infographic

05 Sep 2018

In this data-packed visual resource, you will find illuminating information about upcoming patent expirations at the Top 10 pharma companies. Find out which companies have the most patents due to expire soon and over the next three years, which therapy areas will be most affected the sales potential of the top 10 drugs with a US Patent expiry and more.

Topic Drug development landscape

View infographic

Datamonitor Healthcare

Meningococcal Vaccines Forecast Infographic

By Karolina Kujawa 28 Aug 2018

Over 1.2 million cases of bacterial meningitis are estimated to occur worldwide each year. If not treated promptly, up to half of those cases will be fatal. This infographic from Datamonitor Healthcare provides a snapshot of the meningococcal vaccines market in the US and five major EU markets. What does the meningococcal vaccines market have in store and how will it affect your business? Download now.

Topic Vaccines

View infographic

Sitetrove

Sitetrove Roundup Infographic Issue 5

22 Aug 2018

22,734 investigators were added to Sitetrove in 2017 across 130 countries, with the US having the greatest number added (4,391), and the total number reaching 416,577+ in April 2018. Download the 5th issue of Sitetrove Roundup now and discover the top 10 countries with newly added clinical investigators in 2017, trial starts 2007-2017, how each disease compares, the top 10 diseases with newly identified investigators in 2017, and more!

Topic Clinical trials

View infographic

Biomedtracker

Biomedtracker Q3 2018 Outlook Infographic

22 Aug 2018

For a look at the outcomes for predicted Q2 2018 catalysts, we invite you to download a free copy of the data-rich Catalyst Roundup infographic from Biomedtracker. This informative graphic takes a look at the outcomes for two major catalysts featured in Biomedtracker’s insightful Q2 2018 Outlook Report.

Topic Drug development landscape

View infographic

Medtech Insight

Global Approvals Infographic

25 Jul 2018

Meddevicetracker recorded 62 medical device approvals from outside the United States in the first quarter for 2018, including 46 CE Marks from Europe.

Topic Medtech

View infographic

Scrip

Pharma's 2018 Deal-Making Story, So Far

By Jo Shorthouse 20 Jul 2018

Pharma has been busy making deals this year, while the political winds of change swirl overhead, as our infographic shows. Companies both big and small have been merging to carve out therapeutic niches, return value to shareholders, and position themselves for the next wave of innovation and change.

Topic Business strategies

View infographic

Pharmapremia

Cancer Treatment is HARD!

10 May 2018

Drug development – it’s an area rife with risk, but with great risk often comes great rewards. An area notoriously prone to failure is oncology, and nowhere is accurate risk assessment more critical. Developing Cancer Treatments is HARD! But is everyone bad at it? is a view into this failure-prone area from Pharmapremia.

Topic Cancer

View infographic
Show More

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.
General enquiry

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now